No products in shopping bag.
Scientific Research on SP Pro-Liver Pills
Sheng-pu Pharmaceutics Co., Ltd. has commissioned a study on the efficacy of liver pills from the US University of Southern California (USC).
Joint effort with research team of University of Southern California
Sheng-Pu has entered its 50th year since its start. With the aim to study Chinese Medicine scientifically, we invested in a four-year research and testing of Chinese herbs in the Pharmacology and Toxicology department as well as the Neuroscience department of USC. The research results have been published in the The American Journal of Chinese Medicine and Hepatology. In addition, the establishment of Sheng-Pu North America factory made it possible to use the latest technology to produce high-quality and curative Chinese herbal medicine under strict quality regulations. We continue to cooperate with American universities and research institutions.
We conduct our research to help spread the wisdom of Chinese medicine to the West and to promote Chinese medicine in the international stage.
History of Sheng-Pu Research
The YGW Research Report from Sheng-Pu Pharmaceutics Co., Ltd
1998 - Begins YGW research at USC
USC researchers find YGW very effective against rats with impaired liver function.
1999 - First YGW Research Report published
“Yang-Gan-Wan Protects Mice Against Experimental Liver Damage ” was published in the American Journal of Chinese Medicine.
2000 - Second YGW Research Report published
“Yang-gan-wan Protects Mice Against Apoptosis Induced by anti-Fas Antibody (Jo2)” was published in the American Journal of Chinese Medicine.
2001 - Third YGW Research Report releases in U.S.
The third YGW Research Report releases in the 52nd Annual Meeting of American Association for the Study of Liver Diseases.
2005 - Third YGW Research Report published
“Hepatoprotective Mechanisms of Yan-gan-wan ” was published in the Hepatology Research.
2007 - YGW Third Research Summary Releases in Japan
YGW Third Research Summary report releases in Japan Digestive Disease Week 2007.
2010 - Fourth YGW Research Report Releases in U.S.
The fourth YGW Research Report releases in the 61st Annual Meeting of American Association for the Study of Liver Diseases.
2011 - YGW Research Report Releases for the First Time in Taiwan
YGW research report releases in the NTU-USC Joint Symposium Frontiers in Liver Disease Research.
2012 - Fourth YGW Research Report published
“Rosmarinic acid and baicalin epigenetically de-repress Pparγ in hepatic stellate cells for their anti-fibrotic effect” was published in the Hepatology.
Research Reports
Since our research reports are published in the journal, we cannot provide the original copy. Here’s a link to the study of SP Pro-liver Pill (YGW) at the National Institutes of Health:
Protective effect of SP Pro-liver Pill (YGW) on chemical liver injury in mice
SP Pro-liver Pill (YGW) protects mice against apoptosis induced by anti-Fas antibody (Jo2)
SP Pro-liver Pill (YGW) protects the liver
Genetic activity of rosemary acid and baicalein in the epigenetic defibrillation of PPARγ in hepatocytes
